Key result
Cancer therapies and other factors potentially trigger AF associated with thromboembolism or bleeding.
Highlights the shared risk factors and potential causal links between atrial fibrillation and breast cancer, including the impact of medical interventions.
Alerts clinicians to AF risks in cancer; leaves open optimal antithrombotic strategies pending prospective data.
Causes and factors potentially leading to atrial fibrillation (AF) in cancer patients and associated with thrombo-embolism (TE) or bleeding in both disorders. Factors shown in red are related to medical interventions. CTRCD, cancer therapy-related cardiac dysfunction, RT, Radiotherapy, TR, thrombosis. Causes and factors potentially leading to atrial fibrillation (AF) in cancer patients and associated with thrombo-embolism (TE) or bleeding in both disorders. Factors shown in red are related to medical interventions. CTRCD, cancer therapy-related cardiac dysfunction, RT, Radiotherapy, TR, thrombosis.
No takes yet. Share an insight, caveat, or question.
José Luís Merino (2021) conducted a review in Atrial fibrillation and breast cancer. Various causes and factors, including medical interventions, potentially lead to atrial fibrillation in cancer patients and are associated with thrombo-embolism or bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: